Related Experiment Videos
Drug-induced toxic epidermal necrolysis in children
W G Jones1, P Halebian, M Madden
1Burn Center, Department of Surgery, New York Hospital-Cornell University Medical Center, New York City 10021.
Insights
This study found that avoiding steroids and antimicrobial agents in treating drug-induced toxic epidermal necrolysis improved patient outcomes. Basic burn care alone reduced sepsis and mortality in pediatric patients.
Area of Science:
- Pediatric Dermatology
- Toxicology
- Infectious Disease Management
Background:
- Drug-induced toxic epidermal necrolysis (TEN) is a severe, life-threatening mucocutaneous reaction.
- Previous treatment strategies often included steroids and antimicrobial agents, potentially impacting host resistance.
- Septic complications are a major concern in TEN management.
Purpose of the Study:
- To evaluate the efficacy of a treatment regimen for pediatric drug-induced TEN.
- To assess the impact of avoiding steroids and antimicrobial agents on patient outcomes.
- To determine if basic burn care alone is sufficient for managing TEN.
Main Methods:
- A cohort of nine pediatric patients with drug-induced TEN was treated.
- The regimen consisted of basic burn care exclusively.
- Steroids and topical or systemic antimicrobial agents were intentionally omitted.
Main Results:
- Neutropenia and gram-negative sepsis were significantly reduced compared to historical controls.
- Overall mortality rates were substantially decreased.
- Wound healing was not negatively affected or prolonged by this approach.
Conclusions:
- Eliminating steroids and sulfa-containing topical agents can improve tolerance to infections in TEN patients.
- Basic burn care without immunosuppressive agents is a viable and effective treatment for pediatric drug-induced TEN.
- This approach minimizes iatrogenic risks and improves patient outcomes, including reduced sepsis and mortality.
Abstract:
Nine pediatric patients with drug-induced toxic epidermal necrolysis were treated with a regimen of basic burn care and without the use of steroids or topical or systemic antimicrobial agents. Although septic complications continue to occur frequently, infections are better tolerated when potential iatrogenic sources of decreased host resistance, such as steroids, are eliminated. Neutropenia, gram-negative sepsis, and mortality were all greatly reduced with this regimen, while healing was neither impaired nor prolonged. Thus, steroids and sulfa-containing topical agents should be avoided in the treatment of this disorder.